201 related articles for article (PubMed ID: 35030969)
1. High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling.
Xi X; Hu Z; Wu Q; Hu K; Cao Z; Zhou J; Liao J; Zhang Z; Hu Y; Zhong X; Bao Y
Bioengineered; 2022 Jan; 13(1):1895-1907. PubMed ID: 35030969
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA Small Nucleolar RNA Host Gene 3 Mediates Prostate Cancer Migration, Invasion, and Epithelial-Mesenchymal Transition by Sponging miR-487a-3p to Regulate
Yu L; Ren Y
Cancer Biother Radiopharm; 2022 Aug; 37(6):451-465. PubMed ID: 33416420
[No Abstract] [Full Text] [Related]
3. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG3 sponges miR-577 to up-regulate SMURF1 expression in prostate cancer.
Li T; Xing Y; Yang F; Sun Y; Zhang S; Wang Q; Zhang W
Cancer Med; 2020 Jun; 9(11):3852-3862. PubMed ID: 32248648
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
7. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
8. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
Hong L; Chen W; Wu D; Wang Y
Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-485-3p promotes proliferation, migration and invasion in prostate cancer through activation of TGF-β signaling.
Chen D; Fan J; Li X; Jiao Z; Tang G; Guo X; Chen H; Wang J; Men T
Histol Histopathol; 2022 May; 37(5):423-430. PubMed ID: 34958117
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
[TBL] [Abstract][Full Text] [Related]
11. ZNF507 affects TGF-β signaling via TGFBR1 and MAP3K8 activation in the progression of prostate cancer to an aggressive state.
Kwon W; Choi SK; Kim D; Kim HG; Park JK; Han JE; Cho GJ; Yun S; Yu W; Han SH; Ha YS; Lee JN; Kwon TG; Cho DH; Yi JK; Kim MO; Ryoo ZY; Park S
J Exp Clin Cancer Res; 2021 Sep; 40(1):291. PubMed ID: 34537073
[TBL] [Abstract][Full Text] [Related]
12. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
13. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
[TBL] [Abstract][Full Text] [Related]
14. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
[TBL] [Abstract][Full Text] [Related]
15. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1.
Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z
Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA SNHG3 accelerates papillary thyroid carcinoma progression via the miR-214-3p/PSMD10 axis.
Sui G; Zhang B; Fei D; Wang H; Guo F; Luo Q
J Cell Physiol; 2020 Oct; 235(10):6615-6624. PubMed ID: 32048306
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
[TBL] [Abstract][Full Text] [Related]
18. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG3 regulates the BMSC osteogenic differentiation in bone metastasis of breast cancer by modulating the miR-1273g-3p/BMP3 axis.
Sun Z; Hu J; Ren W; Fang Y; Hu K; Yu H; Liao D; Liu S; Zhou L; He T; Zhang Y
Biochem Biophys Res Commun; 2022 Feb; 594():117-123. PubMed ID: 35081500
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
